These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15994687)

  • 1. Prioritising neglected diseases related to poverty.
    MacDonald R
    BMJ; 2005 Jul; 331(7507):12. PubMed ID: 15994687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we help one billion sick people?
    Maliski E; Gund P; Brown F
    Curr Opin Drug Discov Devel; 2008 May; 11(3):301-2. PubMed ID: 18428082
    [No Abstract]   [Full Text] [Related]  

  • 3. Broken drug markets in infectious diseases: Opportunities outside the private sector?
    Alpern JD; Dunlop SJ; Stauffer WM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007190. PubMed ID: 30973876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
    Kesselheim AS
    Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 6. Eliminating neglected diseases: impact of published paper.
    Brownback S
    Health Aff (Millwood); 2007; 26(5):1509. PubMed ID: 17848471
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing drugs for developing countries.
    Ridley DB; Grabowski HG; Moe JL
    Health Aff (Millwood); 2006; 25(2):313-24. PubMed ID: 16522573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: drug development for neglected diseases: a public health challenge.
    Fehr A; Thürmann P; Razum O
    Trop Med Int Health; 2006 Sep; 11(9):1335-8. PubMed ID: 16930253
    [No Abstract]   [Full Text] [Related]  

  • 9. Neglected diseases: getting less neglected?
    Senior K
    Drug Discov Today; 2005 Jul; 10(13):878. PubMed ID: 15993802
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinued drugs in 2008: anti-infectives.
    Ryder NS
    Expert Opin Investig Drugs; 2010 Jan; 19(1):1-21. PubMed ID: 20001552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Government action needed to step up research and development for world's most neglected diseases.
    Pecoul B
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495
    [No Abstract]   [Full Text] [Related]  

  • 12. Singapore infectious diseases comes of age.
    Allen DM
    Singapore Med J; 1994 Jun; 35(3):314-5. PubMed ID: 7997913
    [No Abstract]   [Full Text] [Related]  

  • 13. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer.
    Witty A
    Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425
    [No Abstract]   [Full Text] [Related]  

  • 14. Priority setting and the 'neglected' tropical diseases.
    Canning D
    Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):499-504. PubMed ID: 16540135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The great medicines scandal.
    Richards T
    BMJ; 2006 Jun; 332(7554):1345-6. PubMed ID: 16740527
    [No Abstract]   [Full Text] [Related]  

  • 16. Solution to contentious issue of Article 31(f) of TRIPS agreement.
    Janodia MD; Sreedhar D; Ligade VS; Udupa N
    Indian J Med Res; 2008 Jul; 128(1):84-5; author reply 85-86. PubMed ID: 18820365
    [No Abstract]   [Full Text] [Related]  

  • 17. The world's most neglected diseases.
    Yamey G; Torreele E
    BMJ; 2002 Jul; 325(7357):176-7. PubMed ID: 12142292
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic breakthroughs in the millennium: what to look for in the next two decades. Part 2: New therapeutics reverse old thinking.
    Davidson S
    Health Forum J; 1999; 42(2):61-3. PubMed ID: 10538905
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of oral antibiotics in lower-extremity infections.
    Joseph WS; Lefrock J
    Clin Podiatr Med Surg; 1996 Oct; 13(4):683-99. PubMed ID: 8902339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neglected cardiovascular diseases in Africa: challenges and opportunities.
    Mocumbi AO; Ferreira MB
    J Am Coll Cardiol; 2010 Feb; 55(7):680-7. PubMed ID: 20170795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.